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ABSTRACT
Objective: An observational case–control study was
designed to analyse the discriminative value of ultrasound
(US)-detected joint effusion compared with physical
examination in the assessment of sacroiliac joints (SIJ) in
patients with spondyloarthropathy (SpA) with or without
inflammatory back pain (IBP).
Methods: 45 patients with SpA, classified according to
European Spondylarthropathy Study Group criteria, and 30
healthy volunteers were studied. All patients had clinical
evaluation of the SIJ, Bath ankylosing spondylitis (AS)
metrology index, Bath AS disease activity index, Bath AS
functional index, health assessment questionnaire,
patient’s and physician’s visual analogue scale on global
disease activity.
Results: Ultrasound showed joint effusion in 38.9% of SIJ
of patients with SpA and in 1.7% of SIJ of controls
(p,0.001). The presence of IBP was significantly
associated with SIJ effusion assessed by US alone or plus
at least one SIJ test. SIJ effusion assessed by US alone
or plus at least one SIJ test had a positive likelihood ratio
(LR) (2.67 and 4.04, respectively) for the presence of IBP
higher than LR of single clinical tests. Positive sacral
sulcus test, iliac gapping and midline sacral thrust test
were associated with SIJ effusion assessed by US, but all
clinical tests, singly and in various combinations, had a
low LR for the presence of SIJ effusion assessed by US.
Conclusions: The study suggests that high resolution
sonography is useful in the assessment of SIJ involve-
ment in SpA, resulting in images that are fast and
inexpensive and may locate, complementing the physical
examination, the origin of IBP.
The sacroiliac joints (SIJ) may be a hallmark of all
spondyloarthropathy (SpA) subsets, such as anky-
losing spondylitis (AS), psoriatic arthritis and
undifferentiated SpA. The inflammation of these
joints may be unilateral or bilateral, with different
levels of severity. Inflammatory back pain (IBP)
and sacroiliitis occur in all SpA subsets and rarely
inflammation of the axial skeleton occurs in the
absence of sacroiliitis.1
Many physical examination tests have been
advocated as diagnostic aids in patients with SIJ
pain, but examination findings are not consistently
capable of identifying involvement of SIJ.2
Interpreting SIJ tests is difficult, because the
variations in anatomy and motion in the SIJ are
accompanied by movements of the lumbar spine
and hip.3 Moreover, none of the available SIJ tests
appears to be superior to others3 and the reliability
of these tests has also been questioned.2
Musculoskeletal ultrasound plays an increasing
and relevant role in the evaluation of SpA mainly
for its ability to assess joint and periarticular soft
tissue involvement and in particular for its capacity
to detect enthesitis. Nevertheless, so far very few
papers on US evaluation of the SIJ have been
published, even though it has been demonstrated
that signs of active synovitis could be detected
with this diagnostic tool.4
We designed an observational case–control study
to analyse the discriminative value of sonographic-
detected joint effusion compared with physical
examination in the assessment of SIJ in patients
with SpA with or without IBP.
PATIENTS AND METHODS
We studied 45 consecutive patients with axial SpA
(AS 19; psoriatic arthritis 6; undifferentiated SpA
20), classified according to European
Spondylarthropathy Study Group criteria5 referred
to the rheumatology clinic at Sapienza University
of Rome. Thirty healthy volunteers (60 SIJ) with-
out suspicion of inflammatory low back pain
served as a control group.
Our study was conducted in compliance with
good clinical practice, following the routine mon-
itoring procedures performed in our unit for
patients with SpA.
According to Calin et al6 IBP referred to the
lumbosacral or buttock region was defined if four
of the five following factors were present: (1) onset
of back discomfort before the age of 40 years; (2)
insidious onset; (3) persistence for at least
3 months; (4) associated with morning stiffness;
(5) improvement with exercise. At the time of the
evaluation, the presence or absence of IBP was
assessed on the basis of the second question of the
Bath ankylosing spondylitis disease activity index
(BASDAI).
Patients were initially assessed by a single
rheumatologist (GB) who took the clinical history
and performed the physical examination, including
clinical evaluation of the SIJ, Bath AS metrology
index,7 BASDAI,8 Bath AS functional index,9 health
assessment questionnaire10 and the patient’s and
physician’s visual analogue scale on global disease
activity (0–100 mm). Physical examination for the
suspicion of SIJ abnormalities included:
c Sacral sulcus tenderness (referred to tenderness
immediately medial to the posterior superior
iliac spine);11
c Iliac gapping (with the patient positioned
supine, the examiner crossed his arms, placed
the heels of his hands on the anterosuperior
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iliac spines and pressed downward and laterally);12
c Iliac compression (with the patient positioned lying on his
side, the examiner exerted a downward force on the
uppermost iliac crest);12
c Midline sacral thrust test (the examiner applies a poster-
oanterior force to the sacrum as the patient lies prone);13
c Gaenslen’s test (the patient lies supine as the contralateral
hip is flexed and the ipsilateral hip is extended);11 13
c Patrick’s test (stress of the SIJ by flexion, abduction and
external rotation of the hip).11
The results of these tests are considered positive if the
manoeuvres provoke pain at the right or left SIJ.
The erythrocyte sedimentation rate and C-reactive protein
were measured and applied as biological signs of inflammation.
All patients and controls underwent evaluation of both SIJ.
Sonographic examinations were performed by a rheumatol-
ogist experienced in musculoskeletal sonography (AI), who was
unaware of the subjects’ signs, symptoms and diagnosis. An
Agilent HP Image Point Hx machine equipped with a linear
probe (7.5 MHz) was used. Patients were examined in the prone
position. The US examination started with the identification of
the bony spinous processes in the midline and the posterior part
of the SIJ, keeping the probe in a transverse position.14 The
posterior contour of the sacrum was visualised as an echogenic
line, whereas the sacral spinous process was shown as a concave
curve at the midline, with sacral wings, represented by a regular
echogenic line laterally. The SIJ was visualised as a hypoechoic
cleft between two echogenic lines (sacrum and iliac bone).14 15
Joint effusion was detected when abnormal hypoechoic or
anechoic intra-articular material that was displaceable and
compressible but did not exhibit Doppler signal was present
within the joint space.16 The finding was recorded according to
an absent–present criterion.
Interreader reliability for sonographic recorded images,
between two trained examiners (AI and FC), was established
in 36 SIJ of 18 patients, randomly included independently of the
presence or absence of IBP at the time of the evaluation.
Intrareader reliability was established on recorded images in 36
SIJ with blinding to previous results and to the patient’s
identity. The intrareader reliability was limited to the analysis
of recorded images and was not performed on the entire process,
which included image acquisition, because the single operator
could remember, within a few days, the previous findings and
would not have been blinded.
Statistical analysis
Categorical variables were analysed by the x2 test or Fisher’s
exact test when one of the expected cell frequencies was smaller
than five. The results were presented as median (25th–75th
percentile) and the significance of the differences was deter-
mined using the Mann–Whitney test for unpaired samples and
Wilcoxon’s test for paired samples.
The sensitivity, specificity and likelihood ratio (LR) have been
calculated with 95% CI. For the reliability analysis, the two-
way mixed effect model (absolute agreement) and single
measure intraclass correlation coefficients were used.
Statistical significance was accepted at two-sided p,0.05.
RESULTS
The main clinical and demographic features of 45 patients with
SpA are shown in table 1. The mean age (42 years, range 20–68)
and gender ratio (M/F 17/13) of controls were comparable with
those of SpA patients. Clinical evaluation showed at least one
positive test of SIJ in 82.2% of SpA patients and in none of the
controls.
US showed joint effusion in 35 of 90 (38.9%) SIJ of patients
with SpA (fig 1) and in one of the 60 (1.7%) SIJ of the controls
(p,0.001). The interreader (0.827) and intrareader (0.945)
reliability were very good. At the study entry, 28 (62.2%) of
45 patients with SpA had IBP referred to the lumbosacral region.
The rate of US effusion and positive tests of SIJ in SpA patients
with (n = 28) or without (n = 17) IBP referred to the
lumbosacral region is shown in table 2. The sensitivity,
specificity and LR of SIJ effusion and clinical tests for the
presence of IBP are shown in table 3. The rate of positive SIJ
tests in SpA patients with (n = 35) or without (n = 55) US
effusion of SIJ was shown in table 4. The sensitivity, specificity
Table 1 Main clinical and demographic features of 45 patients with
SpA
Feature Value
M/F, n 26/19
Mean age, years 43 (range 22–67)
Mean age at symptom onset, years 35 (range 18–67)
Mean disease duration, months 99 (range 3–600)
BASDAI 4.4 (2.6–5.6)*
BASMI 2.5 (1–4)*
BASFI 3.0 (1.3–5.5)*
HAQ 0.625 (0.31–1.375)*
VAS patient, cm 5 (3.4–6.5)*
VAS physician, mm 4 (3.1–5.6)*
Erythrocyte sedimentation rate, mm/h 18 (7–34)*
C-reactive protein, mg/l 3 (1–11.25)*
Treatment, n (%)
Corticosteroids 17 (37.7)
NSAID 29 (62.2)
DMARD 12 (26.7)
Anti-TNF drugs 22 (48.9)
*Median (25th–75th percentile). BASDAI, Bath ankylosing spondylitis disease activity
index; BASFI, Bath ankylosing spondylitis functional index; BASMI, Bath ankylosing
spondylitis metrology index; DMARD, disease-modifying antirheumatic drug; HAQ,
health assessment questionnaire; NSAID, non-steroidal anti-inflammatory drug; SpA,
spondyloarthropathy; TNF, tumour necrosis factor; VAS, visual analogue scale.
Figure 1 Sonography of the right sacroiliac joint in a patient with
spondyloarthropathy, using an Agilent HP Image Point Hx machine
equipped with a linear probe (7.5 MHz). Posterior transverse scan. Joint
effusion (*) within the sacroiliac joint is demonstrated. Arrows: bone
profile of the sacroiliac joint.
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and LR of SIJ clinical tests for SIJ effusion assessed by US are
shown in table 5.
DISCUSSION
IBP is the key symptom of axial involvement in SpA and is
present in the great majority of patients with AS and in
approximately 70% of all patients with SpA.5 17 18 Moreover,
patients with IBP related to SpA are most likely to move on to
AS and may develop a chronic disabling disease. This symptom
was considered in the European Spondylarthropathy Study
Group5 and SA19 classification criteria. IBP is initially felt
primarily deep in the gluteal region, is localised in SIJ but is
occasionally referred towards the iliac crest, greater trochanteric
or down to the dorsal thigh.19
Many physical examination tests have been advocated as
useful tools in identifying patients with SIJ pain.20 21 There are
two types of clinical tests in the assessment of SIJ involvement:
motion palpation tests to assess movement; pain provocation
tests to stress SIJ structures with the aim of reproducing the
patient’s symptoms. Motion palpation tests rely on the
detection of SJI movements, which are very limited.
Moreover, these tests require palpation of landmarks that can
vary in anatomy and are influenced by soft tissue tension.
Another limit is the lack of specificity for pain provocation tests
that not only stress the SIJ but also stress the lumbar spine, the
hips and soft tissues over the SIJ.21 SIJ motion tests are thus
questionable even if some support exists for the use of pain
provocation tests.22 Among the more frequently used provoca-
tion tests we can consider sacral sulcus tenderness,11 iliac
gapping,12 iliac compression,12 midline sacral thrust test,13
Gaenslen’s test11 13 and Patrick’s test.11 Nevertheless, clinical
studies have for the most part demonstrated that physical
examination findings are not consistently capable of identifying
abnormalities of SIJ as pain generators.23–25 In addition, Dreyfuss
et al26 found 20% of asymptomatic adults had positive findings
on three commonly performed SIJ provocation tests.
Reproducibility has been found to be greater for provocative
tests than for mobility and alignment assessments, but the
validity and reliability of SIJ tests is debated.2 Whereas some
studies found moderate to high interexaminer reliability, other
studies did not confirm it.2
None of the available SIJ tests thus appears to be clearly
superior to others.2 3 21 27 In clinical practice conclusions based
on the results of several tests seem to be supported by the
evidence that clusters of more pain provocation tests showed
good reliability.27 These observations are confirmed by our
results showing the lack of association of a single SJI test with
the presence of IBP. In fact, a significant association was
observed only when we considered a cluster of these tests.
Nevertheless, it is interesting to note that in our study the
presence of IBP was significantly associated with SIJ effusion
assessed by US alone or plus at least one SIJ test. The diagnostic
value of a test can be expressed as the LR, which combines into
one value the sensitivity and specificity of it. Our results
showed that SIJ effusion assessed by US alone or plus at least
one SIJ test had a positive LR (2.67 and 4.04, respectively) for
the presence of IBP higher than the LR of single clinical tests
used for the suspicion of SIJ abnormalities. However, the LR of
Table 2 Rate of US effusion and positive tests of SIJ in SpA patients with (n = 28) or without (n = 17)
IBP referred to the lumbosacral region
IBP present
n (%)
IBP absent
n (%) p Value
US effusion 22 (78.6) 5 (29.4) 0.0011
Sacral sulcus tenderness 22 (78.6) 9 (52.9) 0.071
Iliac gapping 11 (39.3) 3 (17.6) 0.123
Iliac compression 8 (28.6) 4 (23.5) 1.000*
Midline sacral thrust test 15 (53.6) 5 (29.4) 0.203
Gaenslen’s test 13 (46.4) 7 (41.2) 0.972
Patrick’s test 15 (53.6) 5 (29.4) 0.203
Positive SIJ tests >2 23 (82.1) 7 (41.2) 0.012
Positive SIJ tests >3 18 (64.3) 5 (29.4) 0.049
Positive SIJ tests >4 14 (50.0) 2 (11.8) 0.022
US effusion plus positive SIJ test >1 20 (71.4) 3 (17.6) 0.0014
*Fisher’s exact test.
IBP, inflammatory back pain; SIJ, sacroiliac joint; SpA, spondyloarthropathy; US, ultrasound.
Table 3 Sensitivity, specificity and LR of SIJ effusion and clinical tests for the presence of IBP
Sensitivity
(95% CI)
Specificity
(95% CI)
LR positive
(95% CI)
LR negative
(95% CI)
US effusion 0.79 (0.58 to 0.91) 0.71 (0.44 to 0.89) 2.67 (1.25 to 5.72) 0.30 (0.14 to 0.65)
Sacral sulcus tenderness 0.79 (0.58 to 0.91) 0.47 (0.24 to 0.71) 1.48 (0.91 to 2.42) 0.45 (0.20 to 1.05)
Iliac gapping 0.39 (0.22 to 0.59) 0.82 (0.56 to 0.95) 2.23 (0.72 to 6.86) 0.73 (0.53 to 1.02)
Iliac compression 0.29 (0.14 to 0.49) 0.76 (0.50 to 0.92) 1.21 (0.43 to 3.43) 0.93 (0.71 to 1.22)
Midline sacral thrust test 0.54 (0.34 to 0.72) 0.71 (0.44 to 0.89) 1.82 (0.81 to 4.11) 0.66 (0.42 to 1.03)
Gaenslen’s test 0. 46 (0.28 to 0.66) 0.59 (0.33 to 0.80) 1.13 (0.56 to 2.26) 0.91 (0.59 to 1.39)
Patrick’s test 0.54 (0.34 to 0.72) 0.71 (0.44 to 0.89) 1.82 (0.81 to 4.10) 0.66 (0.42 to 1.03)
Positive SIJ test >2 0.75 (0.55 to 0.89) 0.59 (0.33 to 0.80) 1.82 (0.99 to 3.34) 0.42 (0.21 to 0.87)
Positive SIJ test >3 0.68 (0.48 to 0.83) 0.76 (0.50 to 0.92) 2.88 (1.18 to 7.05) 0.42 (0.24 to 0.75)
Positive SIJ test >4 0.57 (0.37 to 0.75) 0.82 (0.56 to 0.95) 3.23 (1.10 to 9.49) 0.52 (0.33 to 0.82)
US effusion plus positive SIJ test >1 0.71 (0.51 to 0.86) 0.82 (0.56 to 0.95) 4.04 (1.41 to 11.60) 0.35 (0.19 to 0.64)
IBP, inflammatory back pain; LR, likelihood ratio; SIJ, sacroiliac joint; US, ultrasound.
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IBP for axial SpA is only 3.1, indicating the limited value of this
parameter when considered alone in the diagnosis of SpA.28
The clinical value of SIJ effusion assessed by US, according to
the OMERACT definition,16 is also sustained by the evidence of
a positive LR of 18 for SpA when we considered healthy
controls. However, a limitation of this study is the lack of
comparison with patients having back pain from other origins.
These findings confirmed the previous few results on the
usefulness of US in the evaluation of SIJ.17–19 24 US guidance can
also be useful for local therapeutic injections of SIJ, allowing to
have a 76.7% of success in positioning the needle in the SIJ15.
Contrast-enhanced colour Doppler US seems to be a very
sensitive technique in the detection of active sacroiilitis.29
Increased perfusion around or inside the SIJ is detected by
colour Doppler US in 48% of patients with sacroiliitis, but also
in some patients with osteoarthritis and in controls.14
More recently, colour and duplex Doppler US of SIJ,
thoracolumbar and paraspinal areas showed that vascularisation
was increased in patients with active disease therapy,?
compared with controls and significantly lowered after anti-
TNF-alpha, suggesting that colour and duplex Doppler US
might be an alternative to magnetic resonance imaging in order
to evaluate response to therapy.30 Nevertheless, it is well known
that Doppler techniques may have low sensitivity in the
detection of flow in deep areas such as SIJ and that their
sensitivity is strictly influenced by the quality of the US
equipment. Therefore, in our study we evaluated the presence/
absence of effusion without using Doppler in order to assess the
relationship between effusion and pain provocation tests and to
suggest to clinicians a fast and useful bedside tool without the
need for high-quality US machines, which are not commonly
available in most rheumatology units and that often need
expert operators. Positive sacral sulcus tenderness and midline
sacral thrust test were associated with SIJ effusion assessed by
US, with the highest sensitivity (71%) for sacral sulcus
tenderness and the highest specificity (85%) for iliac gapping.
Nevertheless, all clinical tests, singly and in various combina-
tions, for SIJ had a low LR for the presence of SIJ effusion
assessed by US.
In conclusion, our study suggests that high resolution
sonography is useful in the assessment of SIJ involvement in
SpA, resulting in images that are fast and inexpensive and may
locate, complementing the physical examination, the origin of
IBP. A limit of our study is the lack of comparison of US with
magnetic resonance imaging. On the other hand, we would also
like to point out that ultrasonographic detection of SIJ effusion
is easy to perform, representing a quick but valuable bedside
procedure that could be used directly by the clinician while
assessing the patient with IBP and SpA. It requires standard and
not sophisticated US equipment, available in most rheumatol-
ogy units, thus suggesting that this diagnostic method could
represent a relevant tool in clinical practice. Nevertheless, the
value of US in patients with SpA should be confirmed by future
research focused on clearly distinguishing inflammatory and
degenerative SIJ diseases.
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